Stresam (etifoxine) is an anxiolytic prescribed for the psychological and somatic manifestations of anxiety. In recent years, online research has linked this medication to potential weight loss, fueling expectations that neither pharmacology nor health authorities confirm.
Etifoxine and metabolism: why Stresam does not affect weight
Etifoxine, the active ingredient in Stresam, modulates certain GABA-A receptors and stimulates the production of endogenous neurosteroids. This mechanism targets the regulation of anxiety, not lipid metabolism or satiety.
See also : Everything You Need to Know About Removable Shoulder Straps: Definition, Benefits, and Everyday Uses
The clinical trials summarized in the opinion of the Transparency Commission (HAS) focus exclusively on the reduction of anxiety scores, compared to benzodiazepines or placebo. No judgment criteria related to body weight or body mass index were included in these protocols.
The Public Database of Medicines, updated by ANSM in November 2024, does not list weight loss as an indication or an expected pharmacological effect. The association between Stresam and slimming stems from a common confusion: when anxiety decreases, eating behavior may change.
See also : Everything You Need to Know About Home Loans: Tips and Tricks for Smart Investing
Some people eat less, but the effect cannot be attributed to the molecule itself. It results from the reduction of stress that was disrupting appetite. An article detailing the side effects of Stresam on weight loss helps to better distinguish these two phenomena.
Side effects of Stresam: skin and liver signals to monitor
The side effect profile of Stresam does not include documented weight variation. The warning signals are of a completely different nature.
- Severe skin reactions (rashes, urticaria, angioedema) are among the rare but serious side effects, requiring immediate cessation of treatment and emergency consultation.
- Liver damage (jaundice, elevated transaminases) has been reported in pharmacovigilance, which necessitates particular vigilance in individuals with fragile liver conditions.
- Drowsiness may occur at the beginning of treatment, with an increased risk if the medication is combined with alcohol consumption.
These effects are infrequent, but their potential severity partly explains the position of the independent review Prescrire, which classifies etifoxine among the medications to be avoided due to a favorable risk-benefit ratio.
Dosage of Stresam and duration of treatment: what the doctor prescribes
Stresam is available in the form of etifoxine hydrochloride capsules. The usual dosage is determined by the doctor based on the intensity of anxiety.
The maximum recommended duration does not exceed twelve weeks. Beyond that, the therapeutic benefit is no longer demonstrated, and the treated individual unnecessarily exposes themselves to side effects. This time limit clearly distinguishes Stresam from a long-term solution: it is a short-term solution for an anxious episode, not a long-term treatment.
A often overlooked point: Stresam is no longer reimbursed by Health Insurance. In 2020, HAS issued an unfavorable opinion on maintaining reimbursement for psychosomatic manifestations of anxiety, considering the medical service provided insufficient in this indication. Therefore, the cost remains entirely the patient’s responsibility.
Stresam, benzodiazepines, and alternatives: criteria for choosing anxiety treatment
One of the arguments in favor of Stresam is the absence of documented physical dependence, unlike benzodiazepines (Xanax, Lexomil). This is a real advantage for patients for whom the risk of dependence is a concern, but it is not enough to guarantee superior efficacy.
Benzodiazepines act more quickly, and their anxiolytic efficacy is better supported by clinical literature. Their major drawback, tolerance and difficult withdrawal, remains a legitimate barrier to prolonged prescription.
For those seeking an effect on anxiety without a heavy chemical molecule, herbal-based specialties (valerian, passionflower) or supplements like Euphytose exist, but their level of clinical evidence is even weaker. The choice of treatment is a discussion with the doctor, who assesses the intensity of the disorders, the history, and the individual tolerance profile.
Anxiety and eating behavior: the real link with weight
Chronic anxiety alters eating behavior in varying ways. Some people eat more under the influence of cortisol (compulsive snacking, craving for sugar), while others lose their appetite. Treating anxiety, regardless of the medication used, can therefore lead to weight gain or loss depending on the initial profile.
Attributing this variation to Stresam amounts to confusing the cause (anxiety) and the tool (the medication). A patient whose anxiety caused eating compulsions may indeed lose weight by returning to normal eating behavior, but this result would be identical with any effective anxiety management, including cognitive-behavioral therapy without medication.
Taking Stresam in the hope of losing weight exposes one to almost certain disappointment and unnecessary side effects, with no demonstrated metabolic benefit. The treatment of overweight should follow other paths, guided by a healthcare professional competent in nutrition.